| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| MAHON PAUL A | EVP & GENERAL COUNSEL | C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING | /s/ John S. Hess, Jr. under Power of Attorney | 02 Jan 2026 | 0001231589 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Common Stock | Options Exercise | $1,212,049 | +8,300 | +23% | $146.03 | 45,081 | 02 Jan 2026 | Direct | F1 |
| transaction | UTHR | Common Stock | Sale | $395,595 | -822 | -1.8% | $481.26 | 44,259 | 02 Jan 2026 | Direct | F1, F2 |
| transaction | UTHR | Common Stock | Sale | $230,797 | -479 | -1.1% | $481.83 | 43,780 | 02 Jan 2026 | Direct | F1, F3 |
| transaction | UTHR | Common Stock | Sale | $357,195 | -739 | -1.7% | $483.35 | 43,041 | 02 Jan 2026 | Direct | F1, F4 |
| transaction | UTHR | Common Stock | Sale | $600,825 | -1,240 | -2.9% | $484.54 | 41,801 | 02 Jan 2026 | Direct | F1, F5 |
| transaction | UTHR | Common Stock | Sale | $732,894 | -1,509 | -3.6% | $485.68 | 40,292 | 02 Jan 2026 | Direct | F1, F6 |
| transaction | UTHR | Common Stock | Sale | $550,136 | -1,130 | -2.8% | $486.85 | 39,162 | 02 Jan 2026 | Direct | F1, F7 |
| transaction | UTHR | Common Stock | Sale | $1,063,803 | -2,181 | -5.6% | $487.76 | 36,981 | 02 Jan 2026 | Direct | F1, F8 |
| transaction | UTHR | Common Stock | Sale | $97,830 | -200 | -0.54% | $489.15 | 36,781 | 02 Jan 2026 | Direct | F1, F9 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Stock Option | Options Exercise | $0 | -8,300 | -11% | $0.000000 | 66,700 | 02 Jan 2026 | Common Stock | 8,300 | $146.03 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |
| F2 | This transaction was executed in multiple trades at prices ranging from $480.64 to $481.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $481.66 to $482.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $482.87 to $483.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $484.14 to $485.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | This transaction was executed in multiple trades at prices ranging from $485.39 to $486.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $486.51 to $487.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $487.51 to $488.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F9 | This transaction was executed in multiple trades at prices ranging from $489.06 to $489.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |